0001094891-26-000056.txt : 20260217 0001094891-26-000056.hdr.sgml : 20260217 20260217083916 ACCESSION NUMBER: 0001094891-26-000056 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260217 DATE AS OF CHANGE: 20260217 EFFECTIVENESS DATE: 20260217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PAVmed Inc. CENTRAL INDEX KEY: 0001624326 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 471214177 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573645 FILM NUMBER: 26636738 BUSINESS ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 949-4319 MAIL ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PAXmed Inc. DATE OF NAME CHANGE: 20141105 D 1 primary_doc.xml X0708 D LIVE 0001624326 PAVmed Inc. 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 (917) 813-1828 DELAWARE PAXmed Inc. Corporation true Lishan Aklog 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Executive Officer Director Dennis M. McGrath 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Executive Officer Shaun M. O'Neil 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Executive Officer Michael A. Gordon 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Executive Officer Michael J. Glennon 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Director Sundeep Agrawal 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Director Timothy E. Baxter 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Director Ronald M. Sparks 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Director Debra J. White 360 MADISON AVENUE 25TH FLOOR NEW YORK NY NEW YORK 10017 Director Other Health Care $1,000,001 - $5,000,000 06b false 2026-02-03 false true true true false 0 60000000 30000000 30000000 The company sold 30,000 shares of Series D Convertible Preferred Stock at $1,000 per share, with the investors receiving warrants to purchase an additional 30,000 shares of Series D Convertible Preferred Stock at $1,000 per share. false 14 0 0 0 false PAVmed Inc. /s/ Dennis M. McGrath Dennis M. McGrath President and Chief Financial Officer 2026-02-17